The KEGG pathway analysis indicated that these 212 targets were mainly enriched in PI3K-AKT, MAPK, RAS, EGFR tyrosine kinase inhibitor resistance, ErbB, PD-L1 expression, PD-1 checkpoint pathway in cancer, and TNF signaling pathways. This evidence concerns the gene CD274 and cancer.